JO
BEAM icon

John Overdeck’s Beam Therapeutics BEAM Stock Holding History

John Overdeck’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6M Buy
1,388,227
+177,374
+15% +$5.36M 0.03% 578
2026
Q1 		$28.9M Buy
1,210,853
+90,464
+8% +$2.51M 0.02% 745
2025
Q4 		$31.1M Buy
1,120,389
+741,345
+196% +$18.9M 0.04% 526
2025
Q3 		$9.2M Sell
379,044
-182,477
-32% -$3.63M 0.01% 1009
2025
Q2 		$9.55M Buy
561,521
+192,320
+52% +$3.35M 0.02% 850
2025
Q1 		$7.21M Buy
369,201
+252,113
+215% +$6.6M 0.02% 930
2024
Q4 		$2.9M Buy
117,088
+50,271
+75% +$1.28M 0.01% 1465
2024
Q3 		$1.64M Sell
66,817
-53,948
-45% -$1.39M ﹤0.01% 1797
2024
Q2 		$2.83M Sell
120,765
-238,033
-66% -$5.85M 0.01% 1320
2024
Q1 		$11.9M Buy
+358,798
New +$11.2M 0.03% 598
2023
Q3 		– Sell
-7,400
Closed -$236K – 2958
2023
Q2 		$236K Sell
7,400
-53,900
-88% -$1.75M ﹤0.01% 2594
2023
Q1 		$1.88M Buy
+61,300
New +$2.42M 0.01% 1415
2022
Q4 		– Sell
-198,996
Closed -$9.48M – 2806
2022
Q3 		$9.48M Buy
198,996
+161,878
+436% +$9.23M 0.03% 510
2022
Q2 		$1.44M Sell
37,118
-32,462
-47% -$1.29M ﹤0.01% 1369
2022
Q1 		$3.99M Buy
69,580
+45,214
+186% +$2.97M 0.01% 1022
2021
Q4 		$1.94M Sell
24,366
-191,331
-89% -$16.4M ﹤0.01% 1939
2021
Q3 		$18.8M Buy
215,697
+48,096
+29% +$4.83M 0.04% 494
2021
Q2 		$21.6M Buy
167,601
+133,525
+392% +$10.6M 0.05% 462
2021
Q1 		$2.73M Buy
+34,076
New +$3.24M 0.01% 1468

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

John Overdeck's BEAM Position: Q2 2026 in Review

John Overdeck increased its Beam Therapeutics (BEAM) stake by 15% in Q2 2026, buying an estimated $5.36M and bringing the position to 1,388,227 shares worth $47.6M. The position accounts for 0.03% of the portfolio, ranked #578.

John Overdeck first reported a position in BEAM in Q1 2021 and has held it in 19 quarters since. 276 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • John Overdeck held 1,388,227 shares of Beam Therapeutics worth $47.6M as of Q2 2026.
  • John Overdeck bought 177,374 Beam Therapeutics shares in Q2 2026, an estimated $5.36M.
  • Beam Therapeutics made up 0.03% of John Overdeck's portfolio in Q2 2026, its #578 holding.
  • John Overdeck first reported a position in Beam Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • 276 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.